The central target comes from eight attributed price targets rather than a single consensus number. The range runs from $14 (Morgan Stanley's Craig Hettenbach, Hold) to $30 (Goldman Sachs' Scott Fidel, Buy, down from $35 in August 2026). Other figures include $20 from both Evercore ISI and UBS, $18 from BofA Securities, $17 from Citigroup, and $16 from Barclays and J.P. Morgan (up from $15 in September 2026). The simple average of these eight targets sits at roughly $18.88, which rounds to $19.
The spread is notable. The more cautious Morgan Stanley target lies just above the current price, while the bullish Goldman Sachs target is nearly three times higher. Most analysts highlight GMR Solutions Inc. (NYSE: GMRS)'s dominant EMS franchise, long-duration contracts, and an air transport segment that delivers outsized revenue per trip. More measured views focus on high financial leverage and reimbursement risk. The overall average rating stays firmly in Buy territory.
At a verified close of about $10.99, reaching $19 would require roughly 73% upside, a very large move by any measure. Shares have been volatile since the May 13, 2026 IPO at $15: the stock reached a 52-week high of $15.98 and a low of $9.00 before recovering. The company released its latest quarterly results after the close on November 9, 2026, and the stock fell about 9% the next session before slipping further the following day.
Fundamentally, GMR Solutions Inc. (NYSE: GMRS) generates roughly $5.97 billion in trailing twelve-month revenue and has reported positive net income, with EBITDA near $1.07 billion. Yet the company carries a debt-to-equity ratio above 500%, a legacy of its leveraged structure. I also checked this using Tickeron’s AI Screener to see how the stock compares to others in the industry. Reaching $19 would likely require sustained earnings growth, evidence of margin expansion, and continued balance-sheet improvement rather than a simple valuation re-rating.
Several verified factors could support a higher valuation. GMR Solutions Inc. (NYSE: GMRS) is the largest and only fully integrated national air-and-ground EMS operator, providing scale advantages and durable, contract-driven revenue. Its air transport business accounts for a small share of volume but roughly half of transport revenue, creating a favorable mix shift as air volumes grow. The company has used IPO proceeds to repay borrowings under a first-lien term loan due 2032, indicating progress on de-leveraging. A constructive analyst stance — seven Buys out of eight ratings — reflects confidence in steady revenue growth and expanding margins.
The main obstacle remains financial leverage, which amplifies sensitivity to any earnings shortfall. Reimbursement rates, payor mix, and labor costs in the EMS industry can pressure margins. The sharp post-earnings sell-off shows that the market is currently seeking clear evidence of execution before re-rating the shares. Valuation compression in the healthcare services sector, rising interest rates that increase the cost of servicing high-leverage balance sheets, and any slowdown in air transport volumes could all weigh on the path toward $19.
From a technical standpoint, the 52-week low near $9.00 serves as the key downside support level, while the 52-week high near $15.98 — just above the $15 IPO price — represents the most important resistance zone. The $10 psychological level has acted as a floor in recent sessions. A sustained move toward $19 would first require reclaiming the $12–$13 area, then breaking decisively above the $15.98 prior high that currently caps the stock's range.
Analyst price targets generally reflect a research horizon of about 12 months, though firms rarely publish identical timeframes and some targets have been updated more recently than others. Investors should monitor quarterly earnings and guidance, progress on debt reduction, air transport volume and pricing trends, and any changes to analyst targets. Macroeconomic factors such as interest-rate decisions and labor-cost inflation in healthcare are also relevant given the company's leverage and workforce-intensive model.
I have found Tickeron's AI Daily Buy/Sell Signals helpful for tracking stocks like this one. The tool uses artificial intelligence to monitor thousands of stocks and ETFs, generating Buy, Sell, or Hold signals based on changing market conditions, technical behavior, and AI-driven analysis. It provides an efficient way to spot opportunities and shifting trends alongside fundamental research, which can be especially useful when following names with wide analyst target ranges.
Whether GMR Solutions Inc. (NYSE: GMRS) can reach $19 depends on converting its dominant EMS franchise into sustainable earnings growth while reducing leverage. The target reflects the average of eight analyst price targets spanning $14 to $30 and implies roughly 73% upside from the latest price. Supportive factors — scale, contract-based revenue, and a high-value air transport mix — are balanced against elevated debt and a market that sold the stock after its most recent earnings. Investors should watch de-leveraging progress, margin trends, and analyst revisions rather than treating the average target as a forecast or guarantee.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
Harry Richardson — Algorithmic Trader & Strategy Developer Harry is an algorithmic trader specializing in impulse and breakout trading strategies across cryptocurrency and equity markets. With more than 10 years of experience in developing automated trading systems, he focuses on building structured algorithms designed to capture momentum while maintaining strict risk control. His approach combines quantitative analysis, real-market execution, and continuous performance monitoring. Vitalii prioritizes risk management, drawdown control, and strategy stability over short-term optimization, ensuring algorithms are adaptable to changing market conditions. He has developed and tested hundreds of automated strategies, working extensively with live trading environments, forward testing, and portfolio-level algorithm management. His work centers on transforming trading ideas into fully operational, scalable automated systems.
The 10-day RSI Indicator for GMRS moved out of overbought territory on November 09, 2026. This could be a sign that the stock is shifting from an upward trend to a downward trend. Traders may want to look at selling the stock or buying put options. Tickeron's A.I.dvisor looked at 1 instances where the indicator moved out of the overbought zone. In 1 of the 1 cases the stock moved lower in the days that followed. This puts the odds of a move down at 90%.
The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In 5 of 6 cases where GMRS's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are 83%.
GMRS moved below its 50-day moving average on November 09, 2026 date and that indicates a change from an upward trend to a downward trend.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where GMRS declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 79%.
GMRS broke above its upper Bollinger Band on November 04, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The Momentum Indicator moved above the 0 level on October 12, 2026. You may want to consider a long position or call options on GMRS as a result. In 3 of 5 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 60%.
The Moving Average Convergence Divergence (MACD) for GMRS just turned positive on October 09, 2026. Looking at past instances where GMRS's MACD turned positive, the stock continued to rise in 2 of 2 cases over the following month. The odds of a continued upward trend are 90%.
The 10-day moving average for GMRS crossed bullishly above the 50-day moving average on November 06, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 1 of 1 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 90%.
Following a +9.83% 3-day Advance, the price is estimated to grow further. Considering data from situations where GMRS advanced for three days, in 14 of 20 cases, the price rose further within the following month. The odds of a continued upward trend are 70%.
The Aroon Indicator entered an Uptrend today. In 9 of 14 cases where GMRS Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 64%.
The Tickeron Valuation Rating of 21 (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.851) is normal, around the industry mean (204.532). P/E Ratio (-6.129) is within average values for comparable stocks, (21.572). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (2.498). Dividend Yield (0.000) settles around the average of (0.154) among similar stocks. P/S Ratio (0.502) is also within normal values, averaging (2.688).
The Tickeron Price Growth Rating for this company is 57 (best 1 - 100 worst), indicating fairly steady price growth. GMRS’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron PE Growth Rating for this company is 98 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron SMR rating for this company is 98 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. GMRS’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 83, placing this stock worse than average.
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
Industry HospitalNursingManagement